Ibogaine carries real cardiac risk. This platform holds the whole treatment arc in one record: contraindication screening, QTc and vitals monitoring against protocol-specific intervals, auto-scored assessments, adverse event logging, and integration follow-up out to six months.
Structured contraindication screening — cardiac history, QT-prolonging medications, liver function, substance history — producing a documented cleared, caution or contraindicated decision before any dose is prescribed.
Timed vitals and QTc capture with automatic threshold alerts at 460ms and 500ms, bradycardia below 50bpm, desaturation and hypotension. Alerts are raised in the database, not the browser, so they cannot be missed.
PHQ-9, GAD-7, craving, sleep and mood, auto-scored and banded, charted against treatment milestones so change over the arc of care is visible at a glance.
Every combination of route, formulation, dosing strategy and setting maps to its own checklist, vitals interval and observation window — oral and IV ibogaine HCl, sublingual iboga TA, root bark, flood, titrated, booster and microdose.
Session records, an adverse event register with actions taken, and scheduled 1-week, 1-month, 3-month and 6-month integration follow-ups with assessment batteries attached.
Country, timezone, locale, currency, units and regulatory wording are configuration, not code. Metric or imperial, NZ or anywhere else, with the same clinical core.
Clinicians get a triage-first roster: risk badge, phase, latest QTc, unacknowledged alerts. Patients get a single daily card — mood, cravings, sleep, symptoms, and home vitals for telehealth microdosing — that writes straight into the same chart the prescriber reads.
Three tiers from sole-charge prescriber to multi-region provider network. 21-day trial, no card required to start.
See plans and pricing